SFX by Ex Libris Inc.

Title:	Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity
Source:	Nature [0028-0836] Huh, J R yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Carter, Guy T T. "The evolving role of natural products in drug discovery." Nature reviews. Drug discovery 4.3 (2005): 206-220.
description	2.	Zanin-Zhorov, A. "Protein kinase C-theta mediates negative feedback on regulatory T cell function." Science 328.5976 (2010): 372-376.
description	3.	Ragupathi, G. "Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins." Vaccine 28.26 (2010): 4260-4267.
description	4.	Buonocore, D. "Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology." Nature 464.7293 (2010): 1371-1375.
description	5.	Boebel, T.A. A. "Sulfoxide covalent catalysis: Application to glycosidic bond formation." Angewandte Chemie (International ed.) 42.47 (2003): 5874-5877.
description	6.	Newman, D. "Natural products as sources of new drugs over the period 1981-2002." Journal of natural products 66.7 (2003): 1022-1037.
description	7.	Vederas, J. "Drug Discovery and Natural Products: End of an Era or an Endless Frontier?" Science 325.5937 (2009): 161-165.
description	8.	Newman, D. "Natural products as sources of new drugs over the last 25 years." Journal of natural products 70.3 (2007): 461-477.
description	9.	Newman, David J. "Natural products as sources of new drugs over the period 1981â 2002." Journal of natural products 66.7 (2003): 1022-1037.
description	10.	Adams, M. "Design and synthesis of potent quillaja saponin vaccine adjuvants." Journal of the American Chemical Society 132.6 (2010): 1939-1945.
description	11.	Lawson, C. "The role of patents in biodiversity conservation." Nature Biotechnology 27.11 (2009): 994-995.
description	12.	Spits, H. "The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling." Nature Immunology 12.1 (2011): 21-27.
description	13.	Epperson, Matthew T. "Enantiospecific synthesis of the bridged pyrrolizidine core of asparagamine A: Dipolar cycloadditions of azomethine ylides derived from the sulfonylation of vinylogous amides." Angewandte Chemie (International ed.) 41.10 (2002): 1778-1780.
description	14.	Hammad, H. "Mechanism of action of clinically approved adjuvants." Current opinion in immunology 21.1 (2009): 23-29.
description	15.	Perales, M. "Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma." Molecular therapy 16.12 (2008): 2022-2029.
description	16.	Xu, ZB B. "Catalytic domain crystal structure of protein kinase C-theta (PKC theta)." The Journal of biological chemistry 279.48 (2004): 50401-50409.
description	17.	Golovina, Tatiana N N. "CD28 costimulation is essential for human T regulatory expansion and function." The journal of immunology 181.4 (2008): 2855-68.
description	18.	Salminen, A. "Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging." Ageing research reviews 7.2 (2007): 83-105.
description	19.	Read, A F F. "Evolution and immunology. The economics of immunity." Science 290.5494 (2000): 1104-5.
description	20.	Liu, J. "C2-amidoglycosylation. Scope and mechanism of nitrogen transfer." Journal of the American Chemical Society 124.33 (2002): 9789-9797.